2care4

Name

2care4

Legal name

2care4 ApS

Website

https://2care4.eu

Company type

Private

Founded year

2005

Operating status

Operating

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution & Manufacturing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers (HLAIAJAK)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Pharmaceutical distribution
• Parallel import
• Generic medicines
• Pharmaceutical manufacturing
• Nordic pharmaceuticals

Headquarters

HQ city

Denmark

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D

Revenue model

1. Parallel Import of Pharmaceuticals: Importing original pharmaceutical products from EU/EEA countries and selling them in Denmark and Nordic markets on par with original manufacturer's Danish packaging. Medicine is sourced from wholesalers approved by the medicines agency in respective sourcing countries.
2. Generic Medicine Development and Trade: Development and distribution of generic medicines. Launched first generic (Etodolac) in 2013. Company serves as a distributor for generic medicines in the Nordic region and partners with companies to develop generic products.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

2care4 imports original pharmaceutical products from other EU/EEA countries for sale in Denmark alongside the original manufacturer's Danish packaging, sourcing from approved wholesalers. Through its 2care4 Generics ApS subsidiary, the company also develops and distributes generic medicines, including Etodolac launched in 2013, and acts as a dedicated Nordic distributor partner for generic medicine developers.

Product overview

2care4 is a pharmaceutical company operating two core business segments: Parallel Import and Generics. The Parallel Import division imports original medicines from EU/EEA countries for sale in Denmark. The Generics division (through 2care4 Generics ApS subsidiary) develops and distributes generic medicines, with Distributor Services offered to partners in the Nordic region. The company, founded in 2005 and employing over 300 people across Europe, focuses on human medicine within the EU/EEA markets.

Differentiator

Problem solved

Functional benefit

Brands

• 2care4 Generics: Generic medicine development and trade division of the 2care4 Group

Products and services

• Parallel Import of Pharmaceuticals Importing original pharmaceutical products from other EU/EEA countries and selling them in Denmark alongside the original manufacturer's Danish packaging, sourced from wholesalers approved by the medicines agency in the respective sourcing country. Serves pharmacies and healthcare buyers in Nordic and German markets.
• Generic Medicines Development and distribution of generic medicines, including Etodolac as the first launched product. 2care4 develops generics in-house and partners with generic medicine developers to bring products to Nordic and German markets.
• Distributor Services for Generic Medicines Distribution services for generic medicines in the Nordic region through 2care4 Generics ApS, offering partnership for generic medicine developers seeking to distribute their products in Nordic markets as a dedicated local partner.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• EU/EEA Approved WholesalerscoreChannel Partner/ Reseller/ Distributor2care4 sources parallel imported medicines from wholesalers abroad who are approved by the medicines agency in the respective sourcing country. These approved wholesalers across EU/EEA countries form the foundation of the parallel import supply chain.

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Oriola Corporation: Oriola is a Finnish health and wellbeing company with pharmaceutical distribution and retail pharmacy operations across the Nordics. It is comparable to 2care4 as a Nordic-focused pharma distribution and wholesale platform.
• Tamro (PHOENIX Group): Tamro is Finland's leading pharmaceutical distributor, part of the PHOENIX Group, supplying medicines to pharmacies and hospitals across Finland. It overlaps with 2care4 as a Nordic-focused pharmaceutical wholesaler delivering into Nordic pharmacy networks.
• Orifarm Group: Orifarm is a Danish-headquartered pharmaceutical company specializing in parallel import, generics development, and consumer healthcare distribution across the Nordics and Europe. It is the most directly comparable competitor to 2care4, mirroring its dual parallel-import/generics model and serving Scandinavian pharmacy channels.
• Paranova Group: Paranova is a Sweden-based parallel import pharmaceutical company focused on repackaging and supplying original medicines to Nordic pharmacies. It directly competes with 2care4 in parallel import sourcing and Nordic pharmacy distribution of originator drugs.
• Abcur AB: Abcur is a Swedish pharmaceutical company focused on parallel import and niche pharma products serving the Nordic markets. It competes with 2care4 directly in the parallel import of pharmaceuticals into Scandinavia and shares a similar geographic and product focus.

Broad incumbents

• Sandoz (Novartis): Sandoz is a global leader in off-patent medicines including generics and biosimilars, distributing across Europe with significant Nordic presence. It competes with 2care4 in generic distribution and parallel-trade supply but offers a far broader global portfolio.
• Krka: Krka is a leading Central and Eastern European generic pharmaceutical manufacturer with extensive distribution in the Nordic region. It is comparable to 2care4 as a generic medicine producer/distributor seeking Nordic shelf space, though serving a broader geographic footprint.
• STADA Arzneimittel AG: STADA is a large European-focused generic and consumer healthcare company with broad generic and specialty pharmaceutical offerings across EU markets. It overlaps with 2care4's generics trade and Nordic distribution activities but operates at much greater scale and across many more therapeutic categories.
• Viatris: Viatris is a global healthcare company formed from Mylan and Upjohn, with a substantial generics and off-patent pharmaceuticals portfolio across Europe. It competes with 2care4 in generic pharmaceutical distribution broadly, but with a much more diversified global footprint.
• Teva Pharmaceutical Industries: Teva is one of the world's largest generic pharmaceutical manufacturers and distributors, including strong European and Nordic presence in parallel-distributed and generic products. It operates in the same parallel-trade and generic distribution arena as 2care4 but at vastly greater scale.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/2care4

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 2care4